Interleukin Genetics (ILIU) Inactive 10-Q2009 Q1 Quarterly report

Filed: 14 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absorbed, aggressively, Alternext, Amex, appeal, aware, bank, Bender, broad, care, checking, clarify, classification, compliance, comply, constant, constantly, consummated, create, Cycle, deconsolidation, dedicate, defensive, deferral, delisting, deposit, direct, distinguish, document, education, Eliot, equivalent, evolve, failure, fairly, family, faster, flux, footnote, foregoing, foreseeable, found, framework, full, GAAP, Guide, hearing, higher, important, inaccurate, insight, installation, installed, issuable, listing, loan, long, Lurier, mentioned, mix, movement, negative, negatively, ninety, Nonemployee, notified, NYSE, parent, past, percentage, pilot, policy, practical, practice, redrafted, regain, regular, repayment, replacement, replacing, restated, restructuring, retained, rotating, significantly, stable, standard, strategy, structure, support, threshold, turn, unacceptable, unfavorable, unknown, verify, volume, withstanding, wrong

Removed: acceptance, assessing, assuming, behavior, Bulletin, campaign, cautioned, Chief, collateralized, collectibility, commitment, comparability, comparative, contractual, CPS, dramatically, earlier, existence, expenditure, expire, extending, federally, finance, genetically, identification, incentive, incorporated, incorrect, initiate, institution, insured, intellectual, leverage, materialize, maturity, minimum, multi, notion, office, outlook, periodontal, personalize, Pharmacology, phase, PHS, preacquisition, prohibit, projected, property, prospectively, prove, public, readily, reducing, reference, reliance, remeasured, Rent, role, SAB, SEC, security, separate, simplified, slight, SOGO, space, transfer, underlying, undue, unproven

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ILIU similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18 United States Code), each of the undersigned officers of Interleukin Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report of Form 10-Q for the quarter ended March 31, 2009 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 14, 2009	/s/ Lewis H. Bender
	Lewis H. Bender Chief Executive Officer


Date: May 14, 2009	/s/ Eliot M. Lurier
	Eliot M. Lurier Chief Financial Officer